We are live on ! Find out more
IMMP

Immutep

25 hedge funds and large institutions have $692K invested in Immutep in 2026 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,367% more call options, than puts

Call options by funds: $74K | Put options by funds: $3K

0.64% less ownership

Funds ownership: 1.77%1.13% (-0.64%)

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

4% less funds holding

Funds holding: 2625 (-1)

24% less capital invested

Capital invested by funds: $916K → $692K (-$224K)

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
4
Reduced
8
Closed
12
Calls
$74K
Puts
$3K
Net Calls
+$71K
Net Calls Change
+$55K

IMMP Hedge Fund Activity: Q2 2026 in Review

25 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q2 2026, worth a combined $692K — down 24% from $916K a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of IMMP and 11 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 4 added.

The largest buyer was Vanguard Personalized Indexing Management, opening a new position worth an estimated $156K. The largest seller was UBS Group, cutting an estimated $325K.

  • 25 institutional investors held Immutep (IMMP) as of Q2 2026, down from 26 in Q1 2026.
  • Funds reported $692K of Immutep stock for Q2 2026, down 24% quarter-over-quarter.
  • 11 funds opened new Immutep positions in Q2 2026 and 12 closed out, a net change of -1 holder.
  • The largest Immutep buyer in Q2 2026 was Vanguard Personalized Indexing Management, an estimated $156K added.
  • The largest Immutep seller in Q2 2026 was UBS Group, an estimated $325K sold.

Based on aggregated 13F filings for Q2 2026.